Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 631.83 | 354.59 | 620.11 | 1,368.08 |
Depreciation/ Depletion | 272.67 | 275.43 | 286.78 | 183.47 |
Non- Cash Items | 14.20 | 212.20 | 136.25 | -82.30 |
Changesin Working Capital | -115.49 | -118.26 | -490.79 | -5.87 |
Cashfrom Operating Activities | 803.21 | 723.96 | 552.35 | 1,463.38 |
Capital Expenditures | -327.47 | -443.41 | -425.64 | -659.51 |
Other Investing Cash Flow Items Total | 6.86 | -4.18 | 53.67 | -179.30 |
Cashfrom Investing Activities | -320.61 | -447.59 | -371.97 | -838.81 |
Financing Cash Flow Items | -49.39 | -48.17 | -51.97 | -933.52 |
Total Cash Dividends Paid | -157.25 | -196.56 | -275.19 | 0.00 |
Issuance( Retirement)of Debt Net | -231.23 | -17.23 | 109.81 | -397.99 |
Cashfrom Financing Activities | -437.87 | -261.96 | -217.35 | -597.43 |
Foreign Exchange Effects | 0.00 | -0.01 | 0.00 | -0.93 |
Net Changein Cash | 44.73 | 14.40 | -36.97 | 26.21 |
Cash Interest Paid | 49.37 | 49.70 | 51.92 | 72.94 |
Cash Taxes Paid | 19.85 | 60.70 | 123.43 | 245.44 |
Issuance( Retirement)of Stock Net | - | - | 0.00 | 734.08 |
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks